{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T18:49:11Z","timestamp":1744138151917},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,10,16]],"date-time":"2010-10-16T00:00:00Z","timestamp":1287187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11936-010-0099-0","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T06:59:56Z","timestamp":1287125996000},"page":"614-627","source":"Crossref","is-referenced-by-count":8,"title":["Current and Future Status of Stem Cell Therapy in Heart Failure"],"prefix":"10.1007","volume":"12","author":[{"given":"David A.","family":"D\u2019Alessandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Michler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,16]]},"reference":[{"key":"99_CR1","first-page":"e25","volume":"117","author":"W Rosamond","year":"2008","unstructured":"Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics\u20142008 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25\u2013e146.","journal-title":"Circulation"},{"key":"99_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S, et al.: Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98\u2013102.","journal-title":"Science"},{"key":"99_CR3","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","volume":"104","author":"C Bearzi","year":"2007","unstructured":"Bearzi C, Rota M, Hosoda T, et al.: Human cardiac stem cells. Proc Natl Acad Sci U S A 2007, 104:14068\u201314073.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"99_CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","volume":"114","author":"AP Beltrami","year":"2003","unstructured":"Beltrami AP, Barlucchi L, Torella D, et al.: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763\u2013776.","journal-title":"Cell"},{"key":"99_CR5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ar.a.20388","volume":"288","author":"TJ Nelson","year":"2006","unstructured":"Nelson TJ, Ge ZD, Van Orman J, et al.: Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A Discov Mol Cell Evol Biol 2006, 288:1216\u20131224.","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"99_CR6","first-page":"216","volume":"4","author":"M Molcayni","year":"2007","unstructured":"Molcayni M, Bentz K, Maegele M, et al.: Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J Neurotrauma 2007, 4:216\u2013225.","journal-title":"J Neurotrauma"},{"key":"99_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.109.881433","volume":"122","author":"Y Yoshida","year":"2010","unstructured":"Yoshida Y, Yamanaka S: Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell\u2013based regeneration. Circulation 2010, 122:80\u201387.","journal-title":"Circulation"},{"key":"99_CR8","first-page":"335","volume-title":"Muscle Regeneration","author":"P Rumyantsev","year":"1979","unstructured":"Rumyantsev P: Some comparative aspects of myocardial regeneration. In Muscle Regeneration. By Mauro A. New York: Raven Press; 1979:335\u2013355."},{"key":"99_CR9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1172\/JCI116734","volume":"92","author":"GY Koh","year":"1993","unstructured":"Koh GY, Klug MG, Soonpaa MH, Field LJ: Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest 1993, 92:1548\u20131554.","journal-title":"J Clin Invest"},{"key":"99_CR10","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1172\/JCI119070","volume":"98","author":"CE Murry","year":"1996","unstructured":"Murry CE, Wiseman RW, Schwartz SM, Hauschka SD: Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 1996, 98:2512\u20132523.","journal-title":"J Clin Invest"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nm0898-929","volume":"4","author":"DA Taylor","year":"1998","unstructured":"Taylor DA, Atkins BZ, Hungspreugs P, et al.: Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998, 4:929\u2013933.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"99_CR12","first-page":"I131","volume":"106","author":"S Ghostine","year":"2002","unstructured":"Ghostine S, Carrion C, Souza LC, et al.: Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002, 106(Suppl 1):I131\u2013136.","journal-title":"Circulation"},{"key":"99_CR13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2006.09.011","volume":"42","author":"WR Mills","year":"2007","unstructured":"Mills WR, Mal N, Kiedrowski P, et al.: Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol 2007, 42:304\u2013314.","journal-title":"J Mol Cell Cardiol"},{"key":"99_CR14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","volume":"117","author":"P Menasch\u00e9","year":"2008","unstructured":"\u2022\u2022 Menasch\u00e9 P, Alfieri O, Janssens S, et al.: The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized ized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189 \u20131200.","journal-title":"Circulation"},{"key":"99_CR15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.athoracsur.2008.12.074","volume":"87","author":"H Hamdi","year":"2009","unstructured":"Hamdi H, Furuta A, Bellamy V, et al.: Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 2009, 87:1196\u20131203.","journal-title":"Ann Thorac Surg"},{"key":"99_CR16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000080341","volume":"14","author":"RH Lee","year":"2004","unstructured":"Lee RH, Kim B, Choi I, et al.: Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004, 14:311\u2013324.","journal-title":"Cell Physiol Biochem"},{"key":"99_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MCA.0b013e32801235da","volume":"18","author":"B Li","year":"2007","unstructured":"Li B, Zeng Q, Wang H, et al.: Adipose tissue stromal cells transplantation in rats of acute myocardial infarction. Coron Artery Dis 2007, 18:221\u2013227.","journal-title":"Coron Artery Dis"},{"key":"99_CR18","unstructured":"Randomized clinical trial of adipose-derived stem cells in the treatment of pts with st-elevation myocardial infarction. Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00442806?term=APOLLO&rank=6 . Accessed August 2010."},{"key":"99_CR19","unstructured":"A randomized clinical trial of adipose-derived stem cells in treatment of non revascularizable ischemic myocardium. Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00426868?term=precise&rank=14 . Accessed August 2010."},{"key":"99_CR20","doi-asserted-by":"crossref","first-page":"49430","DOI":"10.1074\/jbc.M402088200","volume":"279","author":"JH Choi","year":"2004","unstructured":"Choi JH, Hur J, Yoon CH, et al.: Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J Biol Chem 2004, 279:49430\u201349438.","journal-title":"J Biol Chem"},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","volume":"24","author":"J Hur","year":"2004","unstructured":"Hur J, Yoon CH, Kim HS, et al.: Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004, 24:288\u2013293.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"99_CR22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.RES.0000168650.23479.0c","volume":"96","author":"M Koyanagi","year":"2005","unstructured":"Koyanagi M, Brandes RP, Haendeler J, et al.: Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circ Res 2005, 96:1039\u20131041.","journal-title":"Circ Res"},{"key":"99_CR23","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.ATV.0000168409.69960.e9","volume":"25","author":"S Murasawa","year":"2005","unstructured":"Murasawa S, Kawamoto A, Horii M, et al.: Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol 2005, 25:1388\u20131394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"99_CR24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ahj.2009.12.021","volume":"159","author":"M Taljaard","year":"2010","unstructured":"Taljaard M, Ward MR, Kutryk MJ, et al.: Tational and design of enhanced angiogenic cell therapy in acute myocardial infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. Am Heart J 2010, 159:354\u2013360.","journal-title":"Am Heart J"},{"key":"99_CR25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1532\/IJH97.05100","volume":"82","author":"F Arai","year":"2005","unstructured":"Arai F, Hirao A, Suda T: Regulation of hematopoiesis and its interaction with stem cell niches. Int J Hematol 2005, 82:371\u2013376.","journal-title":"Int J Hematol"},{"key":"99_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/IR:34:1:13","volume":"34","author":"SG Furness","year":"2006","unstructured":"Furness SG, McNagny K: Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol Res 2006, 34:13\u201332.","journal-title":"Immunol Res"},{"key":"99_CR27","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.279.5356.1528","volume":"279","author":"G Ferrari","year":"1998","unstructured":"Ferrari G, Cusella-De Angelis G, Coletta M, et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528\u20131530.","journal-title":"Science"},{"key":"99_CR28","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1126\/science.290.5497.1779","volume":"290","author":"E Mezey","year":"2000","unstructured":"Mezey E, Chandross KJ, Harta G, et al.: Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000, 290:1779\u20131782.","journal-title":"Science"},{"key":"99_CR29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/81326","volume":"6","author":"E Lagasse","year":"2001","unstructured":"Lagasse E, Connors H, Al-Dhalimy M, et al.: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2001, 6:1229\u20131234.","journal-title":"Nat Med"},{"key":"99_CR30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI12150","volume":"107","author":"KA Jackson","year":"2001","unstructured":"Jackson KA, Majka SM, Wang H, et al.: Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001, 107:1395\u20131402.","journal-title":"J Clin Invest"},{"key":"99_CR31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","volume":"410","author":"D Orlic","year":"2001","unstructured":"Orlic D, Kajstura J, Chimenti S, et al.: Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701\u2013705.","journal-title":"Nature"},{"key":"99_CR32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cardiores.2004.12.013","volume":"66","author":"N Ma","year":"2005","unstructured":"Ma N, Stamm C, Kaminski A, et al.: Human cord blood cells induce angiogenesis following myocardial infarction in NOD\/scid-mice. Cardiovasc Res 2005, 66:45\u201354.","journal-title":"Cardiovasc Res"},{"key":"99_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/01.CIR.0000046450.89986.50","volume":"107","author":"A Kawamoto","year":"2003","unstructured":"Kawamoto A, Tkebuchava T, Yamaguchi J, et al.: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107:461\u2013468.","journal-title":"Circulation"},{"key":"99_CR34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/86498","volume":"7","author":"AA Kocher","year":"2001","unstructured":"Kocher AA, Schuster MD, Szabolcs MJ, et al.: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430\u2013436.","journal-title":"Nat Med"},{"key":"99_CR35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V56.2.289.289","volume":"56","author":"H Castro-Malaspina","year":"1980","unstructured":"Castro-Malaspina H, Gay RE, Resnick G, et al.: Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980, 56:289\u2013301.","journal-title":"Blood"},{"key":"99_CR36","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0022-5223(02)73610-6","volume":"125","author":"S Fukuhara","year":"2003","unstructured":"Fukuhara S, Tomita S, Yamashiro S, et al.: Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J Thorac Cardiovasc Surg 2003, 125:1470\u20131480.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"99_CR37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","volume":"105","author":"C Toma","year":"2002","unstructured":"Toma C, Pittenger MF, Cahill KS, et al.: Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93\u201398.","journal-title":"Circulation"},{"key":"99_CR38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/clc.20470","volume":"32","author":"S Singh","year":"2009","unstructured":"\u2022\u2022Singh S, Arora R, Handa K, et al.: Stem cells improve left ventricular function in acute myocardial infarction. Clin Cardiol 2009, 32:176\u2013180.","journal-title":"Clin Cardiol"},{"key":"99_CR39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/clc.20575","volume":"32","author":"S Zhang","year":"2009","unstructured":"\u2022\u2022Zhang S, Sun A, Xu D, et al.: Impact of timing on efficiency and safety of intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials. Clin Cardiol 2009, 32:458\u2013466.","journal-title":"Clin Cardiol"},{"key":"99_CR40","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjcard.2009.10.060","volume":"105","author":"J Wohrle","year":"2010","unstructured":"Wohrle J, Merkle N, Mailander V, et al.: Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol 2010, 105:804\u2013812.","journal-title":"Am J Cardiol"},{"key":"99_CR41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","volume":"30","author":"M Tendera","year":"2009","unstructured":"Tendera M, Wojakowski W, Ruzyllo W, et al.: Intracoronary infusion of bone marrow-derived selected CD34\u2009+\u2009CXCR4+ cells and nonselected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009, 30:1313\u20131321.","journal-title":"Eur Heart J"},{"key":"99_CR42","doi-asserted-by":"crossref","unstructured":"Arnold R, Villa A, Gutierrex H, et al.: Absence of accelerated atherosclerotic disease progression after intracoronary infusion of bone marrowdervied mononuclear cells in patients with acute myocardial infarctio-angiographic and intravascular ultrasound-results from the terapia cellular aplcada al miocardio pilot study. Am Heart J 2010, 159:1154.e1\u20131154.e8.","DOI":"10.1016\/j.ahj.2010.03.030"},{"key":"99_CR43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.carrev.2009.04.001","volume":"11","author":"R Flores-Ramirez","year":"2010","unstructured":"Flores-Ramirez R, Uribe-Longoria A, Rangel-Fuentes MM, et al.: Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency. Cardiovasc Revasc Med 2010, 11:72\u201378.","journal-title":"Cardiovasc Revasc Med"},{"key":"99_CR44","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/eurjhf\/hfq095","volume":"12","author":"B-E Strauer","year":"2010","unstructured":"\u2022Strauer B-E, Yousef M, Schannwell CM: The acute and long-term effects of intracoronary Stem cell transplantation in 191 patients with chronic heart failure: the STAR-heart study. Eur J Heart Fail 2010, 12:721\u2013729.","journal-title":"Eur J Heart Fail"},{"key":"99_CR45","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JH Hare","year":"2009","unstructured":"\u2022\u2022Hare JH, Traverse JH, Henry TD, et al.: A randomized, double-blind, placebo-controlled, dose escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277\u20132286.","journal-title":"J Am Coll Cardiol"},{"key":"99_CR46","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.amjcard.2009.06.057","volume":"104","author":"M Plewka","year":"2009","unstructured":"\u2022\u2022Plewka M, Krzeminska-Pakula M, Lipiec P, et al.: Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction. Am J Cardiol 2009, 104:1336\u20131342.","journal-title":"Am J Cardiol"},{"key":"99_CR47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/hrt.2008.155077","volume":"95","author":"K Krause","year":"2009","unstructured":"Krause K, Jaquet K, Schneider C, et al.: Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart 2009, 95:1145\u20131152.","journal-title":"Heart"},{"key":"99_CR48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","volume":"2","author":"U Fischer-Rosakat","year":"2009","unstructured":"Fischer-Rosakat U, Assmus B, Seeger FH, et al.: A pilot trial to assess potential effects of selective intracoronary bone marrow derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2009, 2:417\u2013423.","journal-title":"Circ Heart Fail"},{"key":"99_CR49","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.105.575118","volume":"113","author":"GP Meyer","year":"2006","unstructured":"Meyer GP, Wollert KC, Lotz J, et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months\u2019 follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287\u20131294.","journal-title":"Circulation"},{"key":"99_CR50","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","volume":"355","author":"V Schachinger","year":"2006","unstructured":"Schachinger V, Erbs S, Elsasser A, et al.: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210\u20131221.","journal-title":"N Engl J Med"},{"key":"99_CR51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.108.843243","volume":"3","author":"B Assmus","year":"2010","unstructured":"Assmus B, Rolf A, Erbs S, et al.: Clinical outcome 2\u00a0years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010, 3:89\u201396.","journal-title":"Circ Heart Fail"},{"key":"99_CR52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacc.2009.10.059","volume":"55","author":"B Assmus","year":"2010","unstructured":"Assmus B, Tonn T, Seeger FH, et al.: Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. J Am Coll Cardiol 2010, 55:1385\u20131394.","journal-title":"J Am Coll Cardiol"},{"key":"99_CR53","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/hrt.2009.178913","volume":"95","author":"JO Beitnes","year":"2009","unstructured":"Beitnes JO, Hopp E, Lunde K, et al.: Long term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomized, controlled study. Heart 2009, 95:1983\u20131989.","journal-title":"Heart"},{"key":"99_CR54","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","volume":"12","author":"K Lunde","year":"2006","unstructured":"Lunde K, Solheim S, Aakhus S, et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 12:1199\u20131209.","journal-title":"N Engl J Med"},{"key":"99_CR55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ahj.2010.03.039","volume":"160","author":"D Surder","year":"2010","unstructured":"Surder D, Schwitter J, Moccett T, et al.: Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the Swiss multicenter intracoronary stem cells study in acute myocardial infarction (SWISS-AMI). Am Heart J 2010, 160:58\u201364.","journal-title":"Am Heart J"},{"key":"99_CR56","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archinte.167.10.989","volume":"167","author":"A Abdel-Latif","year":"2007","unstructured":"Abdel-Latif A, Bolli R, Tleyjeh IM, et al.: Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989\u2013997.","journal-title":"Arch Intern Med"},{"key":"99_CR57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2009.06.009","volume":"158","author":"JH Traverse","year":"2009","unstructured":"Traverse JH, Henry TD, Vaughn DE, et al.: Rationale and design for TIME: a phase II, randomized, double-blin, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J 2009, 158:356\u2013363.","journal-title":"Am Heart J"},{"key":"99_CR58","unstructured":"The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study). Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01087996?term=poseidon&rank=2 . Accessed August 2010."},{"key":"99_CR59","unstructured":"The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT). Available at http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00768066?term=TAC&rank=9 . Accessed August 2010."},{"key":"99_CR60","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","volume":"114","author":"AP Beltrami","year":"2003","unstructured":"Beltrami AP, Barlucchi L, Torella D, et al.: Adult cardiac stem cells ar multipotent and support myocardial regeneration. Cell 2003, 114:763\u2013776.","journal-title":"Cell"},{"key":"99_CR61","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","volume":"104","author":"C Bearzi","year":"2007","unstructured":"Bearzi C, Rota M, Hosoda T, et al.: Human cardiac stem cells. Proc Natl Acad Sci U S A 2007, 104:14068\u201314073.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"99_CR62","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","volume":"95","author":"E Messina","year":"2004","unstructured":"Messina E, De Angelis L, Frati G, et al.: Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004, 95:911\u2013921.","journal-title":"Circ Res"},{"key":"99_CR63","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1073\/pnas.0405957102","volume":"102","author":"B Dawn","year":"2005","unstructured":"Dawn B, Stein AB, Urbanek K, et al.: Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 2005, 102:3766\u20133771.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"99_CR64","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","volume":"115","author":"RR Smith","year":"2007","unstructured":"Smith RR, Barile L, Cho HC, et al.: Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896\u2013908.","journal-title":"Circulation"},{"key":"99_CR65","doi-asserted-by":"crossref","first-page":"15885","DOI":"10.1073\/pnas.0907622106","volume":"106","author":"C Bearzi","year":"2009","unstructured":"Bearzi C, Leri A, Lo Monaco F, et al.: Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A 2009, 106:15885\u201315890.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"99_CR66","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.109.207266","volume":"5","author":"DA D\u2019Alessandro","year":"2009","unstructured":"D\u2019Alessandro DA, Kajstura J, Hosoda T, et al.: Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart. Circ Res 2009, 5:1128\u20131140.","journal-title":"Circ Res"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-010-0099-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-010-0099-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-010-0099-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T23:25:05Z","timestamp":1592004305000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-010-0099-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,16]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s11936-010-0099-0","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,16]]}}}